Macrophage-Based Cancer Therapies Show Promise but Face Challenges
By
Carly Cassella
Summary
Scientists are researching macrophages, a type of white blood cell that can fight cancer by consuming cancer cells and signaling other immune cells. While macrophages are a promising target for next-generation cancer therapies, these treatments have so far failed to fully unlock their potential. The article discusses the biology of macrophages and the current state of research into harnessing them for cancer immunotherapy.
Source
Twitter / XMacrophage-Based Cancer Therapies Show Promise but Face Challengessciencealert.comKey quotes
· 3 pulledIts name is derived from the Greek words for 'big' and 'eater', and, as its name suggests, this type of cell has a fierce appetite for cancer.
Macrophages can even sound an 'eat me' alarm from within tumors, kicking other immune players like T Cells into action.
They are a wonderful target for cancer research, but so far, next-generation therapies have largely failed to unlock their true potential.
You might also wanna read
Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer
Sugar shields help immune cells infiltrate tumors' hostile microenvironment to fight cancer
Cancer is not just a mass of rogue cells but a strategically organized "gated community" with its own tumor microenvironment that can keep t
theconversation.com·22d ago
Experimental mRNA cancer vaccine shows tumor-fighting promise in mouse study
An experimental mRNA cancer vaccine developed by the University of Florida, published in Nature Biomedical Engineering, showed promising res
University of Waterloo Researchers Engineer Bacteria to Target and Consume Tumors From Within
Researchers at the University of Waterloo are developing a novel cancer treatment using genetically engineered bacteria that can target and
CRISPR-Engineered Fat Cells Show Promise for Starving Cancer Tumors
Researchers at UC San Francisco have developed a novel cancer treatment approach using CRISPR-engineered fat cells to starve tumors. They tr
ucsf.edu·6mo ago
T cell-myeloid reprogramming overcomes immune resistance in colorectal cancer models
This article presents a scientific study on colorectal cancer (CRC) immunotherapy resistance. It shows that during anti-PD-1 treatment, tumo
Comments
Sign in to join the conversation.
No comments yet. Be the first.